- Home
- OPRX
as 06-20-2025 3:39pm EST
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | WALTHAM |
| Market Cap: | 154.9M | IPO Year: | N/A |
| Target Price: | $10.81 | AVG Volume (30 days): | 338.6K |
| Analyst Decision: | Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.84 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.78 - $15.71 | Next Earning Date: | 08-07-2025 |
| Revenue: | $94,365,000 | Revenue Growth: | 20.66% |
| Revenue Growth (this year): | 14.44% | Revenue Growth (next year): | 10.63% |
Latest OptimizeRx Corporation News
OPRX Breaking Stock News: Dive into OPRX Ticker-Specific Updates for Smart Investing
Business Wire
a day ago
Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions
Simply Wall St.
3 days ago
Calculating The Fair Value Of OptimizeRx Corporation (NASDAQ:OPRX)
Zacks
15 days ago
Here's Why OptimizeRx Corp. (OPRX) is a Great Momentum Stock to Buy
Zacks
17 days ago
New Strong Buy Stocks for June 4th
Zacks
a month ago
Earnings Estimates Rising for OptimizeRx (OPRX): Will It Gain?
GlobeNewswire
a month ago
OptimizeRx to Participate in Upcoming Investor Conferences
Simply Wall St.
a month ago
OptimizeRx First Quarter 2025 Earnings: Beats Expectations
Thomson Reuters StreetEvents
a month ago
Q1 2025 OptimizeRx Corp Earnings Call
Compare OPRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OPRX OptimizeRx Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.